Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

NCT01255410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Metapneumovirus

Interventions

BIOLOGICAL: 10^6 PFU rHMPV-Pa vaccine
BIOLOGICAL: 10^5 PFU rHMPV-Pa vaccine
BIOLOGICAL: Placebo Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)